K
Kai Li
Researcher at Syracuse University
Publications - 264
Citations - 5678
Kai Li is an academic researcher from Syracuse University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 33, co-authored 235 publications receiving 4077 citations. Previous affiliations of Kai Li include Tel Aviv University & Alfred Wegener Institute for Polar and Marine Research.
Papers
More filters
Journal ArticleDOI
Fast, Robust and Accurate Digital Image Correlation Calculation Without Redundant Computations
TL;DR: In this article, a Gauss-Newton-based digital image correlation (DIC) method was proposed to eliminate the redundant computations involved in conventional DIC method using forward additive matching strategy and classic Newton-Raphson (FA-NR) algorithm without sacrificing its sub-pixel registration accuracy.
Journal ArticleDOI
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial
Baohui Han,Kai Li,Qiming Wang,Li Zhang,Jianhua Shi,Zhehai Wang,Ying Cheng,Jianxing He,Yuankai Shi,Yizhuo Zhao,Hao Yu,Yang Zhao,Weiqiang Chen,Yi Luo,Lin Wu,Xiuwen Wang,Robert Pirker,Kejun Nan,Faguang Jin,Jian Dong,Baolan Li,Yan Sun +21 more
TL;DR: Among the Chinese patients in this trial, anlotinib appears to lead to prolonged overall survival and progression-free survival, suggesting that anlot inib is well tolerated and is a potential third-line or further therapy for patients with advanced NSCLC.
Journal ArticleDOI
Web of Science use in published research and review papers 1997–2017: a selective, dynamic, cross-domain, content-based analysis
TL;DR: This is the first study to empirically investigate the documentation of the use of the WoS platform in published academic papers in both scientometric and linguistic terms.
Journal ArticleDOI
A fast digital image correlation method for deformation measurement
TL;DR: A reliability-guided displacement scanning strategy is employed to avoid time-consuming integer–pixel displacement searching for each calculation point, and a pre-computed global interpolation coefficient look-up table is utilized to entirely eliminate repetitive interpolation calculation at sub-pixel locations.
Journal ArticleDOI
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302).
Baohui Han,Kai Li,Yizhuo Zhao,Baolan Li,Ying Cheng,Jianying Zhou,You Lu,Yuankai Shi,Zhehai Wang,Liyan Jiang,Yi Luo,Yiping Zhang,Cheng Huang,Qiang Li,Guoming Wu +14 more
TL;DR: Anlotinib as a third-line treatment provided significant PFS benefits to patients with RA-NSCLC when compared with the placebo, and the toxicity profiles showed good tolerance.